Skip to content

Application of 3D Scanner to Measure Physical Size in Patients With Severe Cerebral Palsy

Physical Measurement in Patients With Severe Cerebral Palsy Using 3D Scanner and Improvement of Manufacturing Techniques for Hip Dislocation Prevention Assistive Devices

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05388422
Enrollment
19
Registered
2022-05-24
Start date
2022-06-02
Completion date
2023-03-31
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy, Spastic

Keywords

3D Scanner, Cerebral palsy, Hip dislocation, Orthotic devices, Protective devices

Brief summary

The aim of this study is to improve the manufacturing techniques of hip brace in preventing progressive hip displacement in patients with severe cerebral palsy, through the measurement of patient's physical size using a 3D scanner.

Detailed description

1. Design : Prospective Study 2. Setting: Hospital rehabilitation department and Home 3. Intervention: Before starting the study, radiologic and clinical evaluation were performed. After measuring the patient's exact physical size by applying a 3D scanner, we manufacture hip brace in preventing progressive hip displacement in patients with severe cerebral palsy. After wearing for a week, follow-up radiologic and clinical evaluation were performed. 4. Main outcome measure 1) Primary outcome: right, left, both hip MI 2) Secondary outcomes: the hip and knee joint range of motion (ROM), pain intensity, satisfaction and discomfort score for the hip brace, quality of life (QOL) of the patients and their caregivers, and the wearability test.

Interventions

DEVICEApplication of 3D scanner to measure physical size in patients with severe cerebral palsy

Before starting the study, radiologic and clinical evaluation were performed. After measuring the patient's exact physical size by applying a 3D scanner, we manufacture hip brace in preventing progressive hip displacement in patients with severe cerebral palsy. After wearing for a week, follow-up radiologic and clinical evaluation were performed.

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

1. diagnosis of cerebral palsy 2. age 1-15 years 3. GMFCS Level IV, V 4. quadriplegia, or diplegia for more than 6 months 5. Patients who have written consent with permission from the child and caregiver.

Exclusion criteria

1. Patients who did not agree to participate in the study 2. Patients who refused the examination 3. Patients who had hip surgery experience 4. Patients who were scheduled to undergo surgery during the clinical study 5. Patients who could not be measured with a 3D scanner

Design outcomes

Primary

MeasureTime frameDescription
Migration index1 weeksHip AP radiography

Secondary

MeasureTime frameDescription
Visual analog scale (Pain index)1 weeksmeasure the pain expressed by score from 0 to 10. The closer to 10, the higher the pain.
Caregiver Priorities & Child Health Index of Life with Disabilities (CPCHILD)1 weeksmeasure the quality of life expressed by score from 0 to 100. The higher the quality of life.
Likert scale (score)1 weeksmeasure the satisfaction, and discomfort about hip protection orthosis expressed by score from 1 to 5. The closer to 1, the higher the satisfaction or comfort.
Range of motion of hip joint1 weeksUsing goniometer, measure the hip and knee abduction and flexion angle expressed by degree from 0' to 180'. The closer to 180', the better the value.
wearability test1 weeksthe Wearability Test consisted of four questions on wearing sensation, five questions about on fit, and four questions on motion suitability evaluation. Each item was scored on 5-point scale, with a total score of 65.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026